Increasing the time‐to‐freezing for clinical apheresis plasma meets quality specifications
Vox Sanguinis · 2023
DOI: 10.1111/vox.13532 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vox Sanguinis, 2023. Verfasst von Kelly M Winter und 5 weiteren Autor:innen. Beteiligte Einrichtung: Research and Development, Australian Red Cross Lifeblood, Alexandria, New South Wales, Australia. Hauptthemen laut MEDLINE: von Willebrand Factor, Blood Component Removal. Die Arbeit nennt 12 Literaturangaben. Gefördert von: Australian Government.
Abstract (Originalsprache)
Background and Objectives In Australia, the vast distances between blood collection centres and processing facilities make it challenging to align supply with demand. Increasing the time to freezing for clinical plasma beyond 6 h would alleviate supply issues. This study aimed to determine the quality of clinical apheresis plasma frozen within 12 h of collection. Materials and Methods Apheresis plasma ( n = 20) collected at donor centres was immediately transported to a blood processing facility, stored at 26°C and sampled aseptically at 6, 8 and 12 h post collection. Frozen samples were thawed, and coagulation factors (F) II, V, VII, VIII and XIII, von Willebrand factor (vWF) and fibrinogen were measured using a coagulation analyser.
Results
FVIII concentrations declined in plasma frozen at 6, 8 and 12 h post collection (1.22 ± 0.27, 1.21 ± 0.25 and 1.16 ± 0.24 IU/mL, respectively) but not significantly ( p = 0.3338). Importantly, all components met the FVIII specification (>0.7 IU/mL) for clinical plasma. Fibrinogen concentrations were stable from 6 to 12 h ( p = 0.3100), as were vWF concentrations ( p = 0.1281). Coagulation factors II, V, VII and XIII were not significantly different ( p > 0.05 for all factors).
Conclusion
Clinical apheresis plasma can be frozen within 12 h of collection, allowing collections from donor centres further from processing centres and increasing supply.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research and Development, Australian Red Cross Lifeblood, Alexandria, New South Wales, Australia.
- Manufacturing and Logistics, Australian Red Cross Lifeblood, Alexandria, New South Wales, Australia.
- Manufacturing and Logistics, Australian Red Cross Lifeblood, West Melbourne, Victoria, Australia.
- Sydney Medical School, The University of Sydney, Camperdown, New South Wales, Australia.
ORCID-Profile: Kelly M Winter, Denese C Marks
Förderung
- Australian Government
Zitieren
APA
Winter, K. M., Webb, R. G., Mazur, E., Ismay, S., Marinakis, D., & Marks, D. C. (2023). Increasing the time‐to‐freezing for clinical apheresis plasma meets quality specifications. Vox Sanguinis. https://doi.org/10.1111/vox.13532
Vancouver
Winter KM, Webb RG, Mazur E, Ismay S, Marinakis D, Marks DC. Increasing the time‐to‐freezing for clinical apheresis plasma meets quality specifications. Vox Sanguinis. 2023. doi:10.1111/vox.13532
BibTeX
@article{Winter2023,
author = {Winter, Kelly M and Webb, Rachel G and Mazur, Eugenia and Ismay, Sue and Marinakis, Dimitra and Marks, Denese C},
title = {Increasing the time‐to‐freezing for clinical apheresis plasma meets quality specifications},
journal = {Vox Sanguinis},
year = {2023},
doi = {10.1111/vox.13532}
}
EUVIMED